valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

F&G Annuities & Life, Inc. (FG) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$17.00 ComplexityHigh Updated
$14.00 $64.82
bear $14.00 base $42.95 bull $64.82 margin of safety $17.00 market price* $19.57
What the business is. F&G Annuities & Life is a US life insurer that mostly sells retirement savings products: fixed indexed annuities, registered index-linked annuities and multi-year guarantee annuities, plus pension risk transfer contracts, funding agreements and indexed universal life. It earns the spread between what its investment portfolio yields and what it credits to policyholders, plus surrender charges and fees. Assets under management before reinsurance were $74.7 billion at June 30, 2026, or $55.9 billion after reinsurance. Fidelity National Financial (FNF) controls the company with about 70% of the common shares after it distributed roughly 12% of F&G to its own shareholders on December 31, 2025. FNF also holds mandatory convertible preferred stock that converts into about 5 million common shares on January 15, 2027. In March 2026, F&G sold its Bermuda reinsurer, F&G Life Re, ceding a $1.8 billion block of business. How we measured earnings. For an annuity writer, reported operating cash flow ($4.7 to $6.0 billion a year from 2023 to 2025) is mostly policyholder and reinsurance money moving through the company, not cash the owners can take out. We therefore use GAAP net earnings available to common shareholders. That figure is already after interest on the company's $2.24 billion of holding-company notes, stock compensation, the preferred dividend, and the amortization of policy acquisition costs. Because borrowing and policyholder funds are the raw material of an insurer, we do not subtract the debt a second time. Per diluted share, earnings were $5.52 in 2022, a loss of $0.47 in 2023 (driven by investment losses), $4.88 in 2024 and $1.88 in 2025. The 2025 figure is after the $17 million preferred dividend; our previous analysis used $2.01, which was before that dividend. We anchor on the median of these four years, $3.38 a share. That covers the business as it has existed since FNF's ownership and the post-2022 accounting basis, and it spans a loss year and two strong years. Earlier years are on a different accounting basis and are excluded. Recent results. Earnings fell 61% in 2025 because alternative-investment income ran about $278 million below the company's own long-term expectation. In the first half of 2026, the company earned $1.24 per diluted share, including a second-quarter loss of $0.62 that the company attributed largely to $144 million of unfavorable mark-to-market effects. Alternative-investment income stayed below expectation, at $93 million for the half. Year 1 of our base case is $2.48, which is that first-half pace annualized. This is above 2025's $1.88 because the first-half 2026 results are already reported, but it remains well below the anchor. Gross sales fell to $2.7 billion in the second quarter from $4.1 billion a year earlier, so we credit no growth from sales. Although assets have grown strongly, per-share earnings have not, and part of that growth was funded with new shares (8 million issued in March 2025). Base case: about $42.95 a share. Earnings of $2.48 in year 1, then $3.38 a share for years 2 to 10. That is the level the business averaged across a mixed run of good and bad investment years, sustained as new annuity sales replace policies that surrender or mature. After year 10, earnings fade 3% a year for 30 years. Nothing in the filings secures new-sales momentum that far out, but the in-force block and distribution network (including the 70% stake in Roar, acquired in January 2024) persist for a long time. The business is worth about $5.84 billion, or $42.95 a share on about 136 million shares counting the preferred conversion. No debt is subtracted because the earnings are already after interest. Converting the preferred removes about $17 million a year of preferred dividends and adds about 5 million shares, which roughly offsets on a per-share basis. Bear case: about $14.00 a share. This is a full credit cycle of the kind life insurers went through in 2008 to 2010, and that F&G showed on a small scale in 2023, when investment losses turned the year into a net loss. Earnings are $1.88 in year 1, then two loss years of $1.95 a share each, an after-tax swing of roughly $520 million a year from the 2025 level as credit losses and impairments hit a portfolio heavy in private credit and alternatives. Earnings then recover only to $1.80 a share for years 4 to 10, reflecting persistently weak alternative returns and costlier funding: the $500 million of 7.40% senior notes due 2028 must be refinanced during the downturn. After that, earnings fade 6% a year for 20 years. The business is worth about $1.90 billion, or $14.00 a share. That is slightly below tangible book value of about $14.77 a share at June 30, 2026 (equity of $4.61 billion less $2.12 billion of goodwill and $0.55 billion of intangibles). We model no forced dilution, because FNF has supported capital before. An offering at depressed prices would push this case lower. Bull case: about $64.82 a share. Year 1 is $2.48 as already reported, then earnings return to $5.20 a share, about the average of 2022 and 2024, for years 2 to 10 as alternative-investment income returns to the long-term level the company expects and spreads hold on the larger book. Earnings fade 3% a year after that. The business is worth about $8.82 billion. What we are least sure of. First, the earnings level: four years of history range from a loss to $5.52, and two of the last six quarters were weak. If $2.48 a share proves to be the true level rather than $3.38, the shares are worth about $32. Second, the investment book: private credit and alternative assets are where a downturn would hit first, and 2023 shows how quickly that becomes a loss. Third, control: FNF decides the timing of any sale of its stake and the capital policy. The worst plausible outcome is a credit downturn that forces capital raising at low prices while a 2028 maturity comes due. The insurance subsidiaries are regulated and policyholder liabilities are long-dated, so a run is unlikely, but common shareholders would be diluted. Margin of Safety price: $17. At $17, the $1.00 annual dividend ($0.25 quarterly) yields close to 6% over the holding period, and the price is only modestly above tangible book of about $14.77, which is close to our bear case. If the base case plays out, from $17 it implies about 23% a year over five years including dividends, or about 39% a year over three years. If the earnings level settles at $2.48 instead, the five-year implied return falls to about 16%. That is why the margin-of-safety price is no higher: it leaves room for that error, which is at least as likely as the bull case. In the bear case the five-year implied return is about 6% a year. At $17, the downside is mostly the credit cycle itself rather than an uncertain earnings level.
Fiscal yearOwner's earningsMethodology
2025 $1.88 ▼
Financial (annuity/life insurer) basis: OE = GAAP net earnings available to common, per diluted share (already after SBC, interest on holding-company debt, and DAC amortization net of capitalization). CFO-based formula not used because CFO ($4,681M) is dominated by policyholder float flows (funds withheld from reinsurers $3,277M, future policy benefits $1,710M), not owner cash. Net earnings $271M; less NCI $6M = $265M attributable to F&G; less $17M FNF preferred dividends = $248M available to common; diluted shares=132M (5M preferred shares excluded as antidilutive); OE/sh=$1.88, matching reported diluted EPS. Corrected 2026-10-16 from $2.01, which had divided $265M (before preferred dividends) by 132M shares. Alternative-investment income ~$278M below management's long-term expectation. Source: FY2025 10-K, accession 0001934850-26-000026.
2024 $4.88 ▼
Financial (annuity/life insurer) basis: OE = GAAP net earnings attributable to common. CFO-based formula not used because CFO ($5,999M) is dominated by policyholder float flows (funds withheld from reinsurers $3,795M, future policy benefits $1,853M), not owner cash. Net earnings attributable=$639M; diluted shares=131M; OE/sh=$4.88. Source: FY2025 10-K, accession 0001934850-26-000026 (also FY2024 10-K 0001934850-25-000015).
2023 -$0.47 ▼
Financial (annuity/life insurer) basis: OE = GAAP net earnings attributable to common. CFO-based formula not used because CFO ($5,834M) is dominated by policyholder float flows (funds withheld from reinsurers $3,386M, future policy benefits $1,325M), not owner cash. Net loss=$(58)M, including $461M of investment losses/impairments; diluted shares=124M; OE/sh=$(0.47). Source: FY2025 10-K, accession 0001934850-26-000026 (also FY2023 10-K 0001934850-24-000018).
2022 $5.52 ▼
Financial (annuity/life insurer) basis: OE = GAAP net earnings attributable to common (already after SBC expense, interest, and DAC amortization net of DAC capitalization). The CFO-based formula is not used because CFO is dominated by policyholder float flows (change in funds withheld from reinsurers, future policy benefits, interest credited), not owner cash. Net earnings=$635M (as recast for LDTI); diluted shares=115M; OE/sh=$5.52. Source: FY2023 10-K, accession 0001934850-24-000018.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States: fixed indexed, registered index-linked and multi-year guarantee annuities and indexed universal life sold nationwide (Northeast, Midwest, South and West) through independent marketing organizations, banks and broker-dealers, with insurance subsidiaries domiciled in Iowa and New York; plus United States institutional pension risk transfer contracts and funding agreements.
Historical growth strategy
Organic growth in annuity and institutional sales (pension risk transfer, funding agreement-backed notes) funded partly with outside capital: a March 2025 common stock offering ($269 million), new holding-company notes, and support from controlling owner Fidelity National Financial. It pairs this with reinsurance and flow-reinsurance arrangements to free capital (including the March 2026 sale of its Bermuda reinsurer F&G Life Re) and with minority or majority stakes in distribution firms, such as the 70% stake in Roar Joint Venture acquired in January 2024.
Chart analysis
F&G has traded only since its December 2022 listing, so the chart is short. A chartist would mark the March 2025 secondary offering at $33.60 as an overhead supply level that the stock has since fallen below. They would note that the company bought back its own shares in the first half of 2026 at an average of about $26 to $27, and would watch that zone as possible support or resistance. They would also flag the roughly 12% share distribution by Fidelity National Financial on December 31, 2025 and the mandatory preferred conversion in January 2027 as sources of new supply. With so little history, they would treat any long-term trend reading as tentative.
Competitors

Companies we consider competitors of FG. Tap a ticker to open our analysis of that company in a new tab.

Circle of competence

We don't have circle of competence information for this company yet.